Thiazolidinediones increase the wingless-type MMTV integration site family (WNT) inhibitor Dickkopf-1 in adipocytes: A link with osteogenesis

Diabetologia

Volumn 53, Issue 3, 2010, Pages 536-540

  Gustafson, B ^a   Eliasson, B ^a   Smith, U ^a  

^a SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Adipocytes; Adipogenesis; Dickkopf 1; Osteogenesis; PPAR ; Thiazolidinediones; WNT signalling

Indexed keywords

ANTIHYPERTENSIVE AGENT; BETA CATENIN; DICKKOPF 1 PROTEIN; GLITAZONE DERIVATIVE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; METFORMIN; PIOGLITAZONE; REPAGLINIDE; ROSIGLITAZONE; SULFONYLUREA; 2,4 THIAZOLIDINEDIONE DERIVATIVE; ANTIDIABETIC AGENT; DKK1 PROTEIN, MOUSE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; SIGNAL PEPTIDE; WNT PROTEIN;

ADD ON THERAPY; ADIPOCYTE; ADIPOGENESIS; ANIMAL CELL; ARTICLE; BONE DEVELOPMENT; CELL DIFFERENTIATION; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED STUDY; DIABETIC PATIENT; DIET THERAPY; DRUG INHIBITION; DRUG MECHANISM; FEMALE; FRACTURE; HUMAN; HYPERLIPIDEMIA; IN VITRO STUDY; MALE; MOUSE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OSSIFICATION; PRIORITY JOURNAL; PROTEIN SECRETION; TREATMENT DURATION; 3T3 CELL LINE; ANIMAL; BIOSYNTHESIS; BONE DENSITY; DIABETES MELLITUS, TYPE 2; GENE EXPRESSION REGULATION; METABOLISM; SIGNAL TRANSDUCTION;

3T3-L1 CELLS; ADIPOCYTES; ANIMALS; BONE DENSITY; DIABETES MELLITUS, TYPE 2; FRACTURES, BONE; GENE EXPRESSION REGULATION; HUMANS; HYPOGLYCEMIC AGENTS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; MICE; OSTEOGENESIS; PPAR GAMMA; SIGNAL TRANSDUCTION; THIAZOLIDINEDIONES; WNT PROTEINS;

EID: 77949272169     PISSN: 0012186X     EISSN: 14320428     Source Type: Journal    
DOI: 10.1007/s00125-009-1615-1     Document Type: Article

References (16)

1. X Yang U Smith 2007 Adipose tissue distribution and risk of metabolic disease: does thiazolidinedione-induced adipose tissue redistribution provide a clue to the answer? Diabetologia 50 1127 1139 10.1007/s00125-007-0640-1 1:CAS:528:DC%2BD2sXkvFKju7g%3D 17393135 (Pubitemid 46701551)
2. A Grey M Bolland G Gamble, et al. 2007 The peroxisome proliferator-activated receptor-gamma agonist rosiglitazone decreases bone formation and bone mineral density in healthy postmenopausal women: a randomized, controlled trial J Clin Endocrinol Metab 92 1305 1310 10.1210/jc.2006-2646 1:CAS:528:DC%2BD2sXksVSrtr4%3D 17264176 (Pubitemid 46556402)
3. SE Kahn B Zinman JM Lachin, et al. 2008 Rosiglitazone-associated fractures in type 2 diabetes: an analysis from A Diabetes Outcome Progression Trial (ADOPT) Diabetes Care 31 845 851 10.2337/dc07-2270 1:CAS:528: DC%2BD1cXmsFGrt7o%3D 18223031
4. AV Schwartz DE Sellmeyer E Vittinghoff, et al. 2006 Thiazolidinedione use and bone loss in older diabetic adults J Clin Endocrinol Metab 91 3349 3354 10.1210/jc.2005-2226 1:CAS:528:DC%2BD28Xpslajt74%3D 16608888 (Pubitemid 44402103)
5. S Benvenuti I Cellai P Luciani, et al. 2007 Rosiglitazone stimulates adipogenesis and decreases osteoblastogenesis in human mesenchymal stem cells J Endocrinol Invest 30 RC26 RC30 1:CAS:528:DC%2BD1cXitFyksg%3D%3D 17993761
6. KR Shockley OP Lazarenko PJ Czernik CJ Rosen GA Churchill B Lecka-Czernik 2009 PPARgamma2 nuclear receptor controls multiple regulatory pathways of osteoblast differentiation from marrow mesenchymal stem cells J Cell Biochem 106 232 246 10.1002/jcb.21994 1:CAS:528:DC%2BD1MXhslehsL0%3D 19115254
7. CA Gregory H Singh AS Perry DJ Prockop 2003 The Wnt signaling inhibitor dickkopf-1 is required for reentry into the cell cycle of human adult stem cells from bone marrow J Biol Chem 278 28067 28078 10.1074/jbc.M300373200 1:CAS:528:DC%2BD3sXlsFKrsrg%3D 12740383 (Pubitemid 36900004)
8. D Diarra M Stolina K Polzer, et al. 2007 Dickkopf-1 is a master regulator of joint remodeling Nat Med 13 156 163 10.1038/nm1538 1:CAS:528: DC%2BD2sXhsVyktbY%3D 17237793 (Pubitemid 46245765)
9. S Yaccoby W Ling F Zhan R Walker B Barlogie JD Shaughnessy Jr 2007 Antibody-based inhibition of DKK1 suppresses tumor-induced bone resorption and multiple myeloma growth in vivo Blood 109 2106 2111 10.1182/blood-2006-09-047712 1:CAS:528:DC%2BD2sXjtFequrY%3D 17068150 (Pubitemid 46348212)
10. MC Politou DJ Heath A Rahemtulla, et al. 2006 Serum concentrations of Dickkopf-1 protein are increased in patients with multiple myeloma and reduced after autologous stem cell transplantation Int J Cancer 119 1728 1731 10.1002/ijc.22033 1:CAS:528:DC%2BD28Xos1Khurc%3D 16646053 (Pubitemid 44258784)
11. JA Kennell OA MacDougald 2005 Wnt signaling inhibits adipogenesis through beta-catenin-dependent and -independent mechanisms J Biol Chem 280 24004 24010 10.1074/jbc.M501080200 1:CAS:528:DC%2BD2MXltlKhurc%3D 15849360 (Pubitemid 40884888)
12. B Gustafson U Smith 2006 Cytokines promote Wnt signaling and inflammation and impair the normal differentiation and lipid accumulation in 3T3-L1 preadipocytes J Biol Chem 281 9507 9516 10.1074/jbc.M512077200 1:CAS:528:DC%2BD28XjtVSruro%3D 16464856 (Pubitemid 43864668)
13. P Isakson A Hammarstedt B Gustafson U Smith 2009 Impaired preadipocyte differentiation in human abdominal obesity: role of Wnt, tumor necrosis factor-alpha, and inflammation Diabetes 58 1550 1557 10.2337/db08-1770 1:CAS:528:DC%2BD1MXos1Cquro%3D 19351711
14. B Mao W Wu Y Li, et al. 2001 LDL-receptor-related protein 6 is a receptor for Dickkopf proteins Nature 411 321 325 10.1038/35077108 1:CAS:528: DC%2BD3MXjvF2qtbo%3D 11357136 (Pubitemid 32467039)
15. N Lee AJ Smolarz S Olson, et al. 2007 A potential role for Dkk-1 in the pathogenesis of osteosarcoma predicts novel diagnostic and treatment strategies Br J Cancer 97 1552 1559 10.1038/sj.bjc.6604069 1:CAS:528:DC%2BD2sXhtlKmt7vO 17987039 (Pubitemid 350175854)
16. JM Gimble S Zvonic ZE Floyd M Kassem ME Nuttall 2006 Playing with bone and fat J Cell Biochem 98 251 266 10.1002/jcb.20777 1:CAS:528: DC%2BD28Xkt1Gkur4%3D 16479589